Derby's Royal Hospital haematology team manages myeloma and lymphoma patients in the East Midlands requiring Bortezomib-based combination regimens. Bortenat 3.5mg provides Derby's oncology pharmacy with a reliable, cost-effective supply of this essential proteasome inhibitor.
The subcutaneous administration route — now standard at Derby and most UK cancer centres — has transformed Bortezomib tolerability, reducing peripheral neuropathy rates from around 24% with IV to under 6% with SC administration while maintaining equivalent anti-myeloma efficacy. Bortenat 3.5mg vials from WHO-GMP certified Indian facilities provide this same treatment at reduced institutional cost.
Visit medshopy.com or WhatsApp +91 82650 41513 for Derby and East Midlands institutional pricing.
The subcutaneous administration route — now standard at Derby and most UK cancer centres — has transformed Bortezomib tolerability, reducing peripheral neuropathy rates from around 24% with IV to under 6% with SC administration while maintaining equivalent anti-myeloma efficacy. Bortenat 3.5mg vials from WHO-GMP certified Indian facilities provide this same treatment at reduced institutional cost.
Visit medshopy.com or WhatsApp +91 82650 41513 for Derby and East Midlands institutional pricing.
What is the shelf life of Bortenat vials and how should they be stored?Bortenat (Bortezomib) 3.5mg powder for injection vials should be stored at room temperature (below 25°C), protected from light, in their original packaging. The typical shelf life is 24-36 months from manufacture date under appropriate storage conditions. Once reconstituted in sodium chloride or glucose solution, the product should be used within 8 hours if stored at room temperature or within 24-48 hours if refrigerated, according to the specific reconstitution instructions. Hospital pharmacies should check batch-specific storage requirements on each certificate of analysis, as conditions can vary slightly by manufacturer.